Impact of leukoaraiosis in patients with acute ischemic stroke treated with thrombectomy: a post hoc analysis of the DIRECT-MT trial.

Abstract

BACKGROUND:

The influence of leukoaraiosis in patients with acute ischemic stroke (AIS) given intra-arterial treatment (IAT) with or without preceding intravenous thrombolysis (IVT) remains unknown.

OBJECTIVE:

To assess the clinical and radiological outcomes of IAT in patients with or without leukoaraiosis.

METHODS:

Patients of the direct mechanical thrombectomy trial (DIRECT-MT) whose leukoaraiosis grade could be assessed were included. DIRECT-MT was a randomized clinical trial performed in China to assess the effect of direct IAT compared with intravenous thrombolysis plus IAT. We employed the Age-Related White Matter Changes Scale for grading leukoaraiosis (ARWMC, 0 indicates no leukoaraiosis, 1-2 indicates mild-to-moderate leukoaraiosis, and 3 indicates severe leukoaraiosis) based on brain CT. The primary outcome was the score on the modified Rankin Scale (mRS) assessed at 90 days.

RESULTS:

There were 656 patients in the trial, 649 patients who were included, with 432 patients without leukoaraiosis, and 217 (33.4%) patients with leukoaraiosis divided into mild-to-moderate (n=139) and severe groups (n=78). Leukoaraiosis was a predictor of a worse mRS score (adjusted OR (aOR)=0.7 (95% CI 0.5 to 0.8)) and higher mortality (aOR=1.4 (1.1 to 1.9)), but it was not associated with symptomatic intracranial hemorrhage (sICH) (aOR=0.9 (0.5 to 1.5)). IVT preceding IAT did not increase sICH risk for patients with no (aOR=1.4 (0.6 to 3.4)), mild-to-moderate (aOR=1.5 (0.3 to 7.8)), or severe (aOR=1.5 (0.1 to 21.3)) leukoaraiosis.

CONCLUSION:

Patients with leukoaraiosis with AIS due to large vessel occlusion are at increased risk of a poor functional outcome after IAT but demonstrate similar sICH rates, and IVT preceding IAT does not increase the risk of sICH in Chinese patients with leukoaraiosis.

• Authors: Tingyu Yi, Yongxin Zhang, Wen-Huo Chen, Yan-Min Wu, Ding-Lai Lin, Xiao-Hui Lin, Lei Zhang, Peng-Fei Xing, Tianxiao Li, Yongwei Zhang, Shouchun Wang, Pengfei Yang, Ming-Zhi Cai, Jianmin Liu, for the DIRECT-MT Investigators
• Journal: Journal of neurointerventional surgery (J Neurointerv Surg) Vol. 15 Issue 2 Pg. 139-145 (Feb 2023) ISSN: 1759-8486 [Electronic] England
• PMID: 35101958 (Publication Type: Randomized Controlled Trial, Journal Article)
• Copyright: © Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Chemical References

• Fibrinolytic Agents

Topics

• Humans
• Stroke (diagnostic imaging, therapy, complications)
• Ischemic Stroke (etiology)
• Brain Ischemia (complications, diagnostic imaging, therapy)
• Treatment Outcome
• Thrombectomy (adverse effects)
• Intracranial Hemorrhages (etiology)
• Leukoaraiosis (complications, diagnostic imaging)
• Thrombolytic Therapy (adverse effects)
• Fibrinolytic Agents (therapeutic use)